Latest Anticonvulsants Stories
Global Epilepsy Market 2014-2018 profiles key players like GlaxoSmithKline plc, Pfizer Inc. and UCB SA.
Findings Presented at 43rd Annual Meeting of the Child Neurology Society MAPLE GROVE, Minn., Oct.
WOODCLIFF LAKE, N.J., Oct. 20, 2014 /PRNewswire/ -- Eisai Inc. announced today that the U.S.
RnRMarketResearch.com adds “Partial Seizure – Pipeline Review, H2 2014” to its store.
MarketOptimizer.org adds “PharmaPoint Epilepsy – Global Drug Forecast and Market Analysis to 2022 – Event-Driven Update” to its store.
NEWARK, Calif., Sept. 5, 2014 /PRNewswire/ -- Depomed, Inc.
- VIMPAT® (lacosamide) C-V approved in the U.S. as monotherapy in the treatment of partial-onset seizures in adults with epilepsy(1) BRUSSELS, Sept.
Eisai Submits Applications for Antiepilepsy Agent Fycompa Simultaneously In Europe and U.S.
Researchers have identified genetic variants that are associated with severe adverse skin reactions to the antiepileptic drug phenytoin.
An Innovative Approach That Puts Clinicians in Charge MAPLE GROVE, Minn., July 28, 2014 /PRNewswire/ -- Upsher-Smith Laboratories,
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.